Abstract:Hepatocellular carcinoma (HCC) is the most common form of primary liver cancer. Accumulating evidence indicates that non-alcoholic steatohepatitis (NASH) is a key predisposing factor for HCC occurrence. However, the precise mechanisms driving NASH transition to HCC remain largely obscure. Augmenter of liver regeneration (ALR) is a sulfhydryl oxidase and cytochrome c reductase that functions as an important regulator of mitochondrial dynamics. In this study, we focused on ALR ubiquitination-mediated degradation and its potential contribution to NASH-driven HCC progression at the mitochondrial level. Hepatic ALR expression in HCC patients was determined using immunohistochemical analysis. Mice with liver-specific deletion of ALR ( ALR CKO ) and ALR WT mice were fed a western diet (WD) and high-sugar solution for induction of NASH. HCC in animals was induced via peritoneal administration of CCl 4 . ALR expression was markedly decreased in liver tissues of patients with NASH and HCC compared with non-NASH and non-tumor tissues. Similarly, in ALR WT mice, the ALR level in tumor tissue was reduced relative to that in para-tumor tissue. In the ALR CKO group, mice fed WD plus CCl 4 developed HCC starting at week 12 while ALR WT mice fed WD plus CCl 4 developed HCC at week 24. Analysis of protein posttranslational modifications revealed ubiquitylation (Ub) and deubiquitination (DUb) of ALR by murine double minute 2 (MDM2) and ubiquitin-specific protease 36 (USP36), respectively. Imbalance between Ub and DUb of ALR resulted in profound ALR degradation, which appeared to be reversibly associated with Edmondson-Steiner tumor grade. Rescue of ALR levels via gene transfection abolished tumor malignant features to a certain extent in vitro. Notably, ALR deletion substantially enhanced mitochondrial fission by activating Drp1 phosphorylation at Ser616, thus disrupting the balance of mitochondrial dynamics between fission and fusion and severely impairing oxidative phosphorylation (OXPHOS) and ATP synthesis, instead enhancing anaerobic metabolism, which might be attributed to steatotic hepatocyte transition into the malignant HCC phenotype. Hepatic ALR depletion via dysregulation of ubiquitination is a critical aggravator of NASH-HCC progression and represents a promising therapeutic target for related liver diseases.

Sel1L-Hrd1 ER-Associated Degradation Suppresses Hepatocyte Hyperproliferation and Liver Cancer

Supplementary Table 1 from EZH2-Mediated Concordant Repression of Wnt Antagonists Promotes β-Catenin–Dependent Hepatocarcinogenesis

HRD1-mediated PTEN Degradation Promotes Cell Proliferation and Hepatocellular Carcinoma Progression.

Integration of Hippo Signalling and the Unfolded Protein Response to Restrain Liver Overgrowth and Tumorigenesis

SEL1L-HRD1 interaction is required to form a functional HRD1 ERAD complex

Repressing of NHERF1 Inhibits Liver Cancer Progression by Promoting the Production of ROS.

Role of SEL1L in the progression of solid tumors, with a special focus on its recent therapeutic potential

Sel1l is Indispensable for Mammalian Endoplasmic Reticulum-Associated Degradation, Endoplasmic Reticulum Homeostasis, and Survival

CYP2E1 plays a suppressive role in hepatocellular carcinoma by regulating Wnt/Dvl2/β-catenin signaling

Elevated Expression of Erbin Destabilizes ERα Protein and Promotes Tumorigenesis in Hepatocellular Carcinoma.

SEL1L preserves CD8+ T-cell survival and homeostasis by fine-tuning PERK signaling and the IL-15 receptor-mediated mTORC1 axis

SEL1L-HRD1 Interaction is Prerequisite for the Formation of a Functional HRD1 ERAD Complex

Sel1L is Indispensable for Mammalian ERAD, ER Homeostasis and Survival

ERCC6L promotes the progression of hepatocellular carcinoma through activating PI3K/AKT and NF-κB signaling pathway

Imbalance in ALR ubiquitination accelerates the progression of nonalcoholic steatohepatitis to hepatocellular carcinoma

Loss of RDM1 Enhances Hepatocellular Carcinoma Progression Via P53 and Ras/Raf/ERK Pathways

Nrf1 is Endowed with a Dominant Tumor-Repressing Effect Onto the Wnt/β-Catenin-Dependent and Wnt/β-Catenin-Independent Signaling Networks in the Human Liver Cancer

Hypomorphic human SEL1L and HRD1 variants uncouple multilayered ER-associated degradation machinery

Endoplasmic Reticulum Associated Degradation (ERAD) Deficiency Promotes Mitochondrial Dysfunction and Transcriptional Rewiring in Human Hepatic Cells

LDLR Inhibition Promotes Hepatocellular Carcinoma Proliferation and Metastasis by Elevating Intracellular Cholesterol Synthesis Through the MEK/ERK Signaling Pathway

TENT5A Mediates the Cancer-Inhibiting Effects of EGR1 by Suppressing the Protein Stability of RPL35 in Hepatocellular Carcinoma.